Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -28,047 | -13,332 | N/A |
| Depreciation Amortization | 834 | 495 | N/A |
| Accounts payable and accrued liabilities | 774 | -43 | N/A |
| Other Working Capital | 2,070 | 56 | N/A |
| Other Operating Activity | 1,104 | 510 | 0 |
| Operating Cash Flow | $-23,265 | $-12,314 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,742 | -1,223 | N/A |
| Net Acquisitions | N/A | 10,486 | N/A |
| Investing Cash Flow | $-1,742 | $9,263 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 11,000 | N/A |
| Debt Repayment | N/A | -4,000 | N/A |
| Common Stock Issued | 79 | 247 | N/A |
| Other Financing Activity | 48,888 | 8,495 | 0 |
| Financing Cash Flow | $48,967 | $15,742 | $N/A |
| Beginning Cash Position | 15,786 | 3,095 | N/A |
| End Cash Position | 39,746 | 15,786 | N/A |
| Net Cash Flow | $23,960 | $12,691 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -23,265 | -12,314 | N/A |
| Capital Expenditure | -1,742 | -1,250 | N/A |
| Free Cash Flow | -25,007 | -13,564 | 0 |